Literature DB >> 22384928

Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.

Naoko Nakamura1, Kumiko Saeki, Masami Mitsumoto, Satoko Matsuyama, Miwako Nishio, Koichi Saeki, Mamoru Hasegawa, Yoshiyuki Miyagawa, Hajime Ohkita, Nobutaka Kiyokawa, Masashi Toyoda, Hidenori Akutsu, Akihiro Umezawa, Akira Yuo.   

Abstract

We have established a serum- and feeder-free culture system for the efficient differentiation of multifunctional hepatocytes from human embryonic stem (ES) cells and three entirely different induced pluripotent stem (iPS) cells (including vector/transgene-free iPS cells generated using Sendai virus vector) without cell sorting and gene manipulation. The differentiation-inducing protocol consisted of a first stage; endoderm induction, second stage; hepatic initiation, and third stage; hepatic maturation. At the end of differentiation culture, hepatocytes induced from human pluripotent stem cells expressed hepatocyte-specific proteins, such as α-fetoprotein, albumin, α1 antitrypsin and cytochrome P450 (CYP3A4), at similar or higher levels compared with three control human hepatocyte or hepatic cell lines. These human iPS/ES cell-derived hepatocytes also showed mature hepatocyte functions: indocyanine green dye uptake (≈ 30%), storage of glycogen (>80%) and metabolic activity of CYP3A4. Furthermore, they produced a highly sensitive hepatotoxicity assay system for D-galactosamine as determined by the extracellular release of hepatocyte-specific enzymes. Hepatoprotective prostaglandin E1 attenuated this toxicity. Interestingly, bile duct-specific enzymes were also detected after drug treatment, suggesting the presence of bile-duct epithelial cells (cholangiocytes) in our culture system. Electron microscopic studies confirmed the existence of cholangiocytes, and an immunostaining study proved the presence of bipotential hepatoblasts with high potential for proliferation. Differentiated cells were transferrable onto new dishes, on which small-sized proliferating cells with hepatocyte markers emerged and expanded. Thus, our differentiation culture system provides mature functional hepatocytes, cholangiocytes, and their progenitors with proliferative potential from a wide variety of human pluripotent stem cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22384928     DOI: 10.1089/cell.2011.0064

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  13 in total

Review 1.  Stem cells and stem cell-derived tissues and their use in safety assessment.

Authors:  Kyle Kolaja
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

2.  Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny.

Authors:  Anangi Balasiddaiah; Daniel Moreno; Laura Guembe; Jesús Prieto; Rafael Aldabe
Journal:  J Physiol Biochem       Date:  2013-05-30       Impact factor: 4.158

3.  Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells.

Authors:  Kartik Subramanian; Derek Jason Owens; Ravali Raju; Meri Firpo; Timothy D O'Brien; Catherine M Verfaillie; Wei-Shou Hu
Journal:  Stem Cells Dev       Date:  2013-10-22       Impact factor: 3.272

Review 4.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

Review 5.  Cellular therapy for liver disease.

Authors:  Robert C Huebert; Jorge Rakela
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

6.  Generation of induced pluripotent stem cells from human Tenon's capsule fibroblasts.

Authors:  Fei Deng; Huiling Hu; Mengfei Chen; Xuerong Sun; Xiaohong Liu; Zhizhang Dong; Ying Liu; Lei Xi; Jing Zhuang; Jian Ge
Journal:  Mol Vis       Date:  2012-11-30       Impact factor: 2.367

Review 7.  Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury.

Authors:  Winfried Krueger; Urs A Boelsterli; Theodore P Rasmussen
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

8.  Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes.

Authors:  Thiago M De Assuncao; Yan Sun; Nidhi Jalan-Sakrikar; Mary C Drinane; Bing Q Huang; Ying Li; Jaime I Davila; Ruisi Wang; Steven P O'Hara; Gwen A Lomberk; Raul A Urrutia; Yasuhiro Ikeda; Robert C Huebert
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

9.  Ductular reaction-on-a-chip: Microfluidic co-cultures to study stem cell fate selection during liver injury.

Authors:  Amranul Haque; Pantea Gheibi; Gulnaz Stybayeva; Yandong Gao; Natalie Torok; Alexander Revzin
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

10.  Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion.

Authors:  Nidhi Jalan-Sakrikar; Thiago M De Assuncao; Jie Lu; Luciana L Almada; Gwen Lomberk; Martin E Fernandez-Zapico; Raul Urrutia; Robert C Huebert
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.